Author | Sample size (treatment group vs. control group) | Difference | 95% CI |
---|---|---|---|
Cabral et al. [57] | 32 (14 vs. 18) | 0.26 mmol/L* | − 0.17 to 0.70 |
Caraccio et al. [58] | 49 (24 vs. 25) | − 0.10 mmol/L* | − 0.27 to 0.07 |
Duman et al. [60] | 39 (20 vs. 19) | 0.004 mmol/L* | − 0.45 to 0.44 |
Iqbal et al. [62] | 64 (32 vs. 32) | 0.00 mmol/L* | − 0.22 to 0.22 |
Liu et al. [64] | 119 (60 vs. 59) | 0.03 mmol/L** | − 0.03 to 0.09 |
Mikhail et al. [66] | 120 (60 vs. 60) | 0.09 mmol/L* | − 0.01 to 0.20 |
Monzani et al. [68] | 45 (23 vs. 22) | − 0.17 mmol/L* | − 0.49 to 0.14 |
Nagasaki et al. [69] | 95 (48 vs. 47) | 0.02 mmol/L** | − 0.12 to 0.16 |
26 (11 vs. 15) | 0.35 mmol/L* | − 0.29 to 0.99 |